{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:58:23Z","timestamp":1793314703301,"version":"4.5.0"},"reference-count":150,"publisher":"Annual Reviews","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:p>More than 90% of central nervous system\u2013directed drug candidates fail because they never reach the brain, and similarly formidable physiological tissue barriers protect the placenta and lymph node. These tissues are walled off by tight junctions, efflux pumps, and immune sentinels that thwart both endogenous and exogenous agents, complicating disease treatment. Here, we detail the microanatomy, transport mechanisms, and pathological shifts of the blood\u2013brain, blood\u2013lymph node, and maternal\u2013fetal barriers. We then benchmark emerging solutions, from receptor-targeted nanoparticles and stimulus-responsive carriers to cell-mediated and bioderived vehicles, against the current landscape of US Food and Drug Administration\u2013approved and experimental therapeutics. By comparing the relatively advanced blood\u2013brain barrier delivery techniques to the immature landscape of lymph node and placental drug delivery, we can advance investigation of these tissues quicker. Leveraging tissue-specific physiology promises higher therapeutic indices, lower systemic toxicity, and faster clinical success and illuminates the priority questions that must be answered over the next decade.<\/jats:p>","DOI":"10.1146\/annurev-bioeng-102723-021307","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:42:39Z","timestamp":1770745359000},"page":"337-359","source":"Crossref","is-referenced-by-count":1,"title":["Advancing Drug Delivery Through Complex Physiological Barriers in the Brain, Lymph Node, and Placenta"],"prefix":"10.1146","volume":"28","author":[{"given":"Katherine M.","family":"Nelson","sequence":"first","affiliation":[{"name":"Department of Biomedical Engineering, University of Delaware, Newark, Delaware, USA; email: gleghorn@udel.edu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Donzanti","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, University of Delaware, Newark, Delaware, USA; email: gleghorn@udel.edu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omkar S.","family":"Mhatre","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, University of Delaware, Newark, Delaware, USA; email: gleghorn@udel.edu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P.","family":"Gleghorn","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, University of Delaware, Newark, Delaware, USA; email: gleghorn@udel.edu"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22","reference":[{"issue":"7","key":"B1","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"B2","article-title":"Diffusion sequence models for enhanced protein representation and generation","year":"2025"},{"key":"B3","article-title":"Protein-protein interaction prediction is achievable with large language models","year":"2023"},{"key":"B4","doi-asserted-by":"crossref","first-page":"e02202","DOI":"10.1002\/adhm.202502202","article-title":"Democratizing organ-on-chip technologies with a modular, reusable, and perfusion-ready microphysiological system","volume":"15","year":"2026","journal-title":"Adv. Healthcare Mater."},{"issue":"1","key":"B5","doi-asserted-by":"crossref","first-page":"ftac026","DOI":"10.1093\/femspd\/ftac026","article-title":"Three-dimensional models of the cervicovaginal epithelia to study host\u2013microbiome interactions and sexually transmitted infections","volume":"80","year":"2022","journal-title":"Pathogens Dis."},{"issue":"1","key":"B6","doi-asserted-by":"crossref","first-page":"H26","DOI":"10.1152\/ajpheart.00552.2022","article-title":"Sex-related external factors influence pulmonary vascular angiogenesis in a sex-dependent manner","volume":"324","year":"2023","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B7","article-title":"Neonatal lung disease: mechanisms driving sex differences","volume-title":"Sex-Based Differences in Lung Physiology","year":"2021"},{"issue":"4","key":"B8","first-page":"314","article-title":"Drug delivery to the central nervous system","volume":"7","year":"2022","journal-title":"Nat. Rev. Mater."},{"key":"B9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: structure, regulation and drug delivery","volume":"8","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"Suppl. 4","key":"B10","first-page":"iv1","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011\u201315","volume":"20","year":"2018","journal-title":"Neuro-Oncology"},{"issue":"5","key":"B11","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1188\/16.CJON.S1.2-8","article-title":"Glioblastoma: overview of disease and treatment","volume":"20","year":"2016","journal-title":"Clin. J. Oncol. Nurs."},{"issue":"15","key":"B12","first-page":"e150861","article-title":"Key molecular alterations in endothelial cells in human glioblastoma uncovered through single-cell RNA sequencing","volume":"6","year":"2021","journal-title":"JCI Insight"},{"key":"B13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","article-title":"The blood-brain barrier in Alzheimer's disease","volume":"107","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"8","key":"B14","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/eji.200838140","article-title":"Distinct molecular composition of blood and lymphatic vascular endothelial cell junctions establishes specific functional barriers within the peripheral lymph node","volume":"38","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"B15","first-page":"387","article-title":"Studies on the structure and permeability of the microvasculature in normal rat lymph nodes","volume":"80","year":"1975","journal-title":"Am. J. Pathol."},{"key":"B16","first-page":"25","article-title":"The popliteal lymph node of the mouse: internal architecture, vascular distribution and lymphatic supply","volume":"148","year":"1986","journal-title":"J. Anat."},{"issue":"5","key":"B17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/01926230600867727","article-title":"Normal structure, function, and histology of lymph nodes","volume":"34","year":"2006","journal-title":"Toxicol. Pathol."},{"issue":"2","key":"B18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1679\/aohc.71.69","article-title":"Structure and function of rat lymph nodes","volume":"71","year":"2008","journal-title":"Arch. Histol. Cytol."},{"issue":"12","key":"B19","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/intimm\/dxn110","article-title":"The conduit system of the lymph node","volume":"20","year":"2008","journal-title":"Int. Immunol."},{"issue":"11","key":"B20","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1111\/j.1349-7006.2010.01687.x","article-title":"Neogenesis and development of the high endothelial venules that mediate lymphocyte trafficking","volume":"101","year":"2010","journal-title":"Cancer Sci"},{"issue":"1","key":"B21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/(SICI)1097-0185(199601)244:1<105::AID-AR10>3.0.CO;2-T","article-title":"Ultrastructural localization of the intercellular adhesion molecule (ICAM-1) on the cell surface of high endothelial venules in lymph nodes","volume":"244","year":"1996","journal-title":"Anat. Record"},{"issue":"3","key":"B22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/bies.950050305","article-title":"Lymphocyte homing receptors and the immune response in vivo","volume":"5","year":"1986","journal-title":"BioEssays"},{"issue":"12","key":"B23","doi-asserted-by":"crossref","first-page":"e3000486","DOI":"10.1371\/journal.pbio.3000486","article-title":"High-resolution 3D imaging and topological mapping of the lymph node conduit system","volume":"17","year":"2019","journal-title":"PLOS Biol"},{"issue":"10","key":"B24","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1084\/jem.192.10.1425","article-title":"Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex","volume":"192","year":"2000","journal-title":"J. Exp. Med."},{"key":"B25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-065X.1986.tb01483.x","article-title":"Homing receptors and the control of lymphocyte migration","volume":"91","year":"1986","journal-title":"Immunol. Rev."},{"issue":"1","key":"B26","doi-asserted-by":"crossref","first-page":"15035","DOI":"10.1038\/nrdp.2015.35","article-title":"HIV infection","volume":"1","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"6","key":"B27","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1073\/pnas.1318249111","article-title":"Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues","volume":"111","year":"2014","journal-title":"PNAS"},{"issue":"2","key":"B28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nm.3445","article-title":"HIV-1 persistence in CD4+ T cells with stem cell-like properties","volume":"20","year":"2014","journal-title":"Nat. Med."},{"issue":"8","key":"B29","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm.1972","article-title":"HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation","volume":"15","year":"2009","journal-title":"Nat. Med."},{"issue":"6629","key":"B30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/387183a0","article-title":"Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection","volume":"387","year":"1997","journal-title":"Nature"},{"issue":"4","key":"B31","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nm.2111","article-title":"HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects","volume":"16","year":"2010","journal-title":"Nat. Med."},{"issue":"9","key":"B32","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/infdis\/jit453","article-title":"Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial","volume":"208","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"2","key":"B33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nm.3781","article-title":"B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers","volume":"21","year":"2015","journal-title":"Nat. Med."},{"issue":"6024","key":"B34","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1126\/science.1203543","article-title":"A perspective on cancer cell metastasis","volume":"331","year":"2011","journal-title":"Science"},{"key":"B35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fonc.2018.00036","article-title":"Growth and immune evasion of lymph node metastasis","volume":"8","year":"2018","journal-title":"Front. Oncol."},{"key":"B36","volume-title":"Cancer facts & figures 2018","year":"2018"},{"key":"B37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addr.2016.08.002","article-title":"Placental control of drug delivery","volume":"116","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"B38","first-page":"84","article-title":"Placental structure, function and drug transfer","volume":"15","year":"2015","journal-title":"Contin. Educ. Anaesth. Crit. Care Pain"},{"issue":"2","key":"B39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s43032-020-00364-7","article-title":"The involvement of cell adhesion molecules, tight junctions, and gap junctions in human placentation","volume":"28","year":"2021","journal-title":"Reproduct. Sci."},{"issue":"3","key":"B40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/molehr\/7.3.279","article-title":"Expression of ZO-1 and occludin in normal human placenta and in hydatidiform moles","volume":"7","year":"2001","journal-title":"Mol. Hum. Reprod."},{"key":"B41","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.addr.2020.09.013","article-title":"Diseases and conditions that impact maternal and fetal health and the potential for nanomedicine therapies","volume":"170","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B42","volume-title":"The World Health Report 2005: make every mother and child count","year":"2005"},{"key":"B43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12864-018-4518-z","article-title":"Identification of placental nutrient transporters associated with intrauterine growth restriction and pre-eclampsia","volume":"19","year":"2018","journal-title":"BMC Genom."},{"key":"B44","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s13669-013-0041-z","article-title":"Intrauterine growth restriction (IUGR): etiology and diagnosis","volume":"2","year":"2013","journal-title":"Curr. Obstet. Gynecol. Rep."},{"issue":"2","key":"B45","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00003081-200606000-00009","article-title":"Adult consequences of fetal growth restriction","volume":"49","year":"2006","journal-title":"Clin. Obstet. Gynecol."},{"issue":"6","key":"B46","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.ajog.2006.03.065","article-title":"Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction","volume":"195","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000477903","article-title":"Update on the diagnosis and prognosis of preeclampsia with the aid of the sFlt-1\/PlGF ratio in singleton pregnancies","volume":"43","year":"2018","journal-title":"Fetal Diagn. Ther."},{"key":"B48","article-title":"Intrauterine growth retardation (IUGR) as a novel condition of insulin-like growth factor-1 (IGF-1) deficiency","volume-title":"Reviews of Physiology, Biochemistry and Pharmacology","volume":"170","year":"2016"},{"issue":"1\u20132","key":"B49","first-page":"51","article-title":"Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction","volume":"112","year":"2007","journal-title":"Clin. Sci."},{"issue":"6","key":"B50","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.ajhg.2025.03.011","article-title":"Advancing precision care in pregnancy through a treatable fetal findings list","volume":"112","year":"2025","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"B51","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/jimd.12659","article-title":"Fetal gene therapy","volume":"47","year":"2024","journal-title":"J. Inherit. Metab. Dis."},{"key":"B52","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jconrel.2021.07.031","article-title":"Does local drug delivery still hold therapeutic promise for brain cancer? A systematic review","volume":"337","year":"2021","journal-title":"J. Control. Release"},{"issue":"6","key":"B53","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41578-019-0110-7","article-title":"Material design for lymph node drug delivery","volume":"4","year":"2019","journal-title":"Nat. Rev. Mater."},{"issue":"22","key":"B54","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1177\/15353702211010762","article-title":"Overcoming physiological barriers by nanoparticles for intravenous drug delivery to the lymph nodes","volume":"246","year":"2021","journal-title":"Exp. Biol. Med."},{"key":"B55","doi-asserted-by":"crossref","first-page":"101534","DOI":"10.1016\/j.smim.2021.101534","article-title":"Innovations in lymph node targeting nanocarriers","volume":"56","year":"2021","journal-title":"Semin. Immunol."},{"issue":"1","key":"B56","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2006.01.006","article-title":"In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles","volume":"112","year":"2006","journal-title":"J. Control. Release"},{"key":"B57","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.actbio.2022.03.054","article-title":"Nanoparticles with dense poly(ethylene glycol) coatings with near neutral charge are maximally transported across lymphatics and to the lymph nodes","volume":"145","year":"2022","journal-title":"Acta Biomater"},{"issue":"2","key":"B58","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.biomaterials.2013.10.003","article-title":"Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response","volume":"35","year":"2014","journal-title":"Biomaterials"},{"issue":"38","key":"B59","doi-asserted-by":"crossref","first-page":"15745","DOI":"10.1073\/pnas.1105200108","article-title":"In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles","volume":"108","year":"2011","journal-title":"PNAS"},{"issue":"3","key":"B60","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41434-024-00508-3","article-title":"Placental nanoparticle-mediated IGF1 gene therapy corrects fetal growth restriction in a guinea pig model","volume":"32","year":"2025","journal-title":"Gene Ther"},{"issue":"3","key":"B61","doi-asserted-by":"crossref","first-page":"eaba1028","DOI":"10.1126\/sciadv.aba1028","article-title":"Ionizable lipid nanoparticles for in utero mRNA delivery","volume":"7","year":"2021","journal-title":"Sci. Adv."},{"issue":"12","key":"B62","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1007\/s13346-023-01369-w","article-title":"Delivery and short-term maternal and fetal safety of vaginally administered PEG-PLGA nanoparticles","volume":"13","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"B63","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jconrel.2018.12.046","article-title":"Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth","volume":"295","year":"2019","journal-title":"J. Control. Release"},{"issue":"576","key":"B64","doi-asserted-by":"crossref","first-page":"eabc6245","DOI":"10.1126\/scitranslmed.abc6245","article-title":"Enhanced drug delivery to the reproductive tract using nanomedicine reveals therapeutic options for prevention of preterm birth","volume":"13","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"B65","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nnano.2007.70","article-title":"Shape effects of filaments versus spherical particles in flow and drug delivery","volume":"2","year":"2007","journal-title":"Nat. Nanotechnol."},{"issue":"22","key":"B66","doi-asserted-by":"crossref","first-page":"e2319880121","DOI":"10.1073\/pnas.2319880121","article-title":"Curvature-mediated rapid extravasation and penetration of nanoparticles against interstitial fluid pressure for improved drug delivery","volume":"121","year":"2024","journal-title":"PNAS"},{"key":"B67","doi-asserted-by":"crossref","first-page":"106678","DOI":"10.1016\/j.vascn.2020.106678","article-title":"Antibodies against polyethylene glycol in human blood: a literature review","volume":"102","year":"2020","journal-title":"J. Pharm. Toxicol. Methods"},{"issue":"12","key":"B68","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s41551-017-0167-9","article-title":"Surveillance nanotechnology for multi-organ cancer metastases","volume":"1","year":"2017","journal-title":"Nat. Biomed. Eng."},{"issue":"7","key":"B69","doi-asserted-by":"crossref","first-page":"e12248","DOI":"10.1002\/jev2.12248","article-title":"Extracellular vesicles engineered to bind albumin demonstrate extended circulation time and lymph node accumulation in mouse models","volume":"11","year":"2022","journal-title":"J. Extracell. Vesicles"},{"issue":"2","key":"B70","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/10611861003734001","article-title":"Targeting the insulin receptor: nanoparticles for drug delivery across the blood\u2013brain barrier (BBB)","volume":"19","year":"2011","journal-title":"J. Drug Target."},{"issue":"10","key":"B71","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/nbt1340","article-title":"Renal clearance of quantum dots","volume":"25","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"B72","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1021\/acsnano.9b01383","article-title":"Elimination pathways of nanoparticles","volume":"13","year":"2019","journal-title":"ACS Nano"},{"key":"B73","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1039\/D3EN00812F","article-title":"Clearance of nanoparticles from blood: effects of hydrodynamic size and surface coatings","volume":"11","year":"2024","journal-title":"Environ. Sci. Nano"},{"key":"B74","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2023.07.029","article-title":"Placental drug transport and fetal exposure during pregnancy is determined by drug molecular size, chemistry, and conformation","volume":"361","year":"2023","journal-title":"J. Control. Release"},{"key":"B75","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconrel.2019.07.026","article-title":"Shape effect in active targeting of nanoparticles to inflamed cerebral endothelium under static and flow conditions","volume":"309","year":"2019","journal-title":"J. Control. Release"},{"issue":"33","key":"B76","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1073\/pnas.0801763105","article-title":"The effect of particle design on cellular internalization pathways","volume":"105","year":"2008","journal-title":"PNAS"},{"key":"B77","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12951-023-02022-x","article-title":"Advances in nanomedicines for lymphatic imaging and therapy","volume":"21","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"B78","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"33","key":"B79","doi-asserted-by":"crossref","first-page":"8521","DOI":"10.1016\/j.biomaterials.2013.07.102","article-title":"Preformed albumin corona, a protective coating for nanoparticles based drug delivery system","volume":"34","year":"2013","journal-title":"Biomaterials"},{"issue":"1","key":"B80","first-page":"100883","article-title":"Recent advances in zwitterionic nanoscale drug delivery systems to overcome biological barriers","volume":"19","year":"2024","journal-title":"Asian J. Pharm. Sci."},{"key":"B81","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jconrel.2024.05.036","article-title":"EGFR-targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta","volume":"371","year":"2024","journal-title":"J. Control. Release"},{"key":"B82","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1210\/en.2012-1832","article-title":"Targeted nanoparticle delivery of doxorubicin into placental tissues to treat ectopic pregnancies","volume":"154","year":"2013","journal-title":"Endocrinology"},{"key":"B83","doi-asserted-by":"crossref","first-page":"101045","DOI":"10.1016\/j.nantod.2020.101045","article-title":"Simultaneous targeting of primary tumor, draining lymph node, and distant metastases through high endothelial venule-targeted delivery","volume":"36","year":"2021","journal-title":"Nano Today"},{"issue":"6","key":"B84","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.celrep.2016.04.007","article-title":"Targeted delivery of immunomodulators to lymph nodes","volume":"15","year":"2016","journal-title":"Cell Rep"},{"issue":"15","key":"B85","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.1021\/am402128s","article-title":"Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations","volume":"5","year":"2013","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"B86","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1038\/s41467-018-04315-4","article-title":"Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles","volume":"9","year":"2018","journal-title":"Nat. Commun."},{"issue":"12","key":"B87","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1016\/j.apsb.2021.04.022","article-title":"A nanocleaner specifically penetrates the blood-brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer's disease","volume":"11","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"14","key":"B88","doi-asserted-by":"crossref","first-page":"2104286","DOI":"10.1002\/advs.202104286","article-title":"Acid-responsive dual-targeted nanoparticles encapsulated aspirin rescue the immune activation and phenotype in autism spectrum disorder","volume":"9","year":"2022","journal-title":"Adv. Sci."},{"issue":"30","key":"B89","doi-asserted-by":"crossref","first-page":"1802227","DOI":"10.1002\/adfm.201802227","article-title":"Acid-responsive transferrin dissociation and GLUT mediated exocytosis for increased blood\u2013brain barrier transcytosis and programmed glioma targeting delivery","volume":"28","year":"2018","journal-title":"Adv. Funct. Mater."},{"issue":"39","key":"B90","doi-asserted-by":"crossref","first-page":"14789","DOI":"10.1039\/D2NR03683E","article-title":"Angiopep-2-decorated titanium\u2013alloy core\u2013shell magnetic nanoparticles for nanotheranostics and medical imaging","volume":"14","year":"2022","journal-title":"Nanoscale"},{"issue":"2","key":"B91","doi-asserted-by":"crossref","first-page":"eabm3381","DOI":"10.1126\/sciadv.abm3381","article-title":"Nanoengineered on-demand drug delivery system improves efficacy of pharmacotherapy for epilepsy","volume":"8","year":"2022","journal-title":"Sci. Adv."},{"issue":"41","key":"B92","doi-asserted-by":"crossref","first-page":"2102953","DOI":"10.1002\/adfm.202102953","article-title":"Binding to amyloid-\u03b2 protein by photothermal blood-brain barrier-penetrating nanoparticles for inhibition and disaggregation of fibrillation","volume":"31","year":"2021","journal-title":"Adv. Funct. Mater."},{"issue":"22","key":"B93","doi-asserted-by":"crossref","first-page":"9805","DOI":"10.1021\/acs.nanolett.1c02996","article-title":"Reversibly modulating the blood\u2013brain barrier by laser stimulation of molecular-targeted nanoparticles","volume":"21","year":"2021","journal-title":"Nano Lett"},{"issue":"11","key":"B94","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1039\/C9NR09713A","article-title":"Microbubbles in combination with focused ultrasound for the delivery of quercetin-modified sulfur nanoparticles through the blood brain barrier into the brain parenchyma and relief of endoplasmic reticulum stress to treat Alzheimer's disease","volume":"12","year":"2020","journal-title":"Nanoscale"},{"key":"B95","doi-asserted-by":"crossref","first-page":"615104","DOI":"10.3389\/fphar.2021.615104","article-title":"Ultrasound combined with microbubbles loading BDNF retrovirus to open blood\u2013brain barrier for treatment of Alzheimer's disease","volume":"12","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B96","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2022.05.042","article-title":"Focused ultrasound\/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain","volume":"348","year":"2022","journal-title":"J. Control. Release"},{"issue":"41","key":"B97","first-page":"2303568","article-title":"Orthogonal design of experiments for engineering of lipid nanoparticles for mRNA delivery to the placenta","volume":"20","year":"2024","journal-title":"Small"},{"issue":"8","key":"B98","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1021\/jacs.2c12893","article-title":"Ionizable lipid nanoparticles for in vivo mRNA delivery to the placenta during pregnancy","volume":"145","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"B99","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bioactmat.2023.11.014","article-title":"Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach","volume":"34","year":"2024","journal-title":"Bioactive Mater"},{"issue":"11","key":"B100","doi-asserted-by":"crossref","first-page":"e2307810121","DOI":"10.1073\/pnas.2307810121","article-title":"Lipid nanoparticle structure and delivery route during pregnancy dictate mRNA potency, immunogenicity, and maternal and fetal outcomes","volume":"121","year":"2024","journal-title":"PNAS"},{"key":"B101","doi-asserted-by":"crossref","first-page":"e00148","DOI":"10.1002\/adtp.202500148","article-title":"Cytokine mRNA delivery and local immunomodulation in the placenta using lipid nanoparticles","volume":"8","year":"2025","journal-title":"Adv. Ther."},{"issue":"34","key":"B102","doi-asserted-by":"crossref","first-page":"e2207841119","DOI":"10.1073\/pnas.2207841119","article-title":"Lipid nanoparticle-mediated lymph node\u2013targeting delivery of mRNA cancer vaccine elicits robust CD8+ T cell response","volume":"119","year":"2022","journal-title":"PNAS"},{"issue":"8","key":"B103","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.1021\/acsnano.8b03900","article-title":"Quantifying the ligand-coated nanoparticle delivery to cancer cells in solid tumors","volume":"12","year":"2018","journal-title":"ACS Nano"},{"key":"B104","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2019.06.033","article-title":"Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma","volume":"307","year":"2019","journal-title":"J. Control. Release"},{"issue":"46","key":"B105","doi-asserted-by":"crossref","first-page":"12644","DOI":"10.1002\/ange.201403846","article-title":"Angiopep-conjugated electro-responsive hydrogel nanoparticles: therapeutic potential for epilepsy","volume":"126","year":"2014","journal-title":"Angew. Chem."},{"issue":"4","key":"B106","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1021\/nn300240p","article-title":"Receptor-mediated delivery of magnetic nanoparticles across the blood\u2013brain barrier","volume":"6","year":"2012","journal-title":"ACS Nano"},{"key":"B107","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.2147\/IJN.S131367","article-title":"A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood\u2013brain barrier, and the transporting mechanism to glioma cells","volume":"12","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"B108","doi-asserted-by":"crossref","first-page":"eabd6889","DOI":"10.1126\/sciadv.abd6889","article-title":"BBB pathophysiology\u2013independent delivery of siRNA in traumatic brain injury","volume":"7","year":"2021","journal-title":"Sci. Adv."},{"issue":"6760","key":"B109","doi-asserted-by":"crossref","first-page":"eads3204","DOI":"10.1126\/science.ads3204","article-title":"Transferrin receptor\u2013targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA","volume":"389","year":"2025","journal-title":"Science"},{"issue":"3","key":"B110","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s13311-016-0431-9","article-title":"Electroresponsive nanoparticles improve antiseizure effect of phenytoin in generalized tonic-clonic seizures","volume":"13","year":"2016","journal-title":"Neurotherapeutics"},{"issue":"5","key":"B111","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1039\/D0BM01765E","article-title":"Targeted graphene oxide for drug delivery as a therapeutic nanoplatform against Parkinson's disease","volume":"9","year":"2021","journal-title":"Biomater. Sci."},{"issue":"11","key":"B112","doi-asserted-by":"crossref","first-page":"eaax7462","DOI":"10.1126\/sciadv.aax7462","article-title":"Brain-targeted enzyme-loaded nanoparticles: a breach through the blood-brain barrier for enzyme replacement therapy in Krabbe disease","volume":"5","year":"2019","journal-title":"Sci. Adv."},{"issue":"8","key":"B113","doi-asserted-by":"crossref","first-page":"11815","DOI":"10.1021\/acsnano.1c10034","article-title":"Signature effects of vector-guided systemic nano bioconjugate delivery across blood-brain barrier of normal, Alzheimer's, and tumor mouse models","volume":"16","year":"2022","journal-title":"ACS Nano"},{"key":"B114","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.bbrc.2020.10.076","article-title":"Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB","volume":"534","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B115","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jconrel.2020.05.033","article-title":"Megalin-targeting liposomes for placental drug delivery","volume":"324","year":"2020","journal-title":"J. Control. Release"},{"key":"B116","doi-asserted-by":"crossref","first-page":"e1600349","DOI":"10.1126\/sciadv.1600349","article-title":"Tumor-homing peptides as tools for targeted delivery of payloads to the placenta","volume":"2","year":"2016","journal-title":"Sci. Adv."},{"issue":"11","key":"B117","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.7150\/thno.18845","article-title":"Placental homing peptide-microRNA inhibitor conjugates for targeted enhancement of intrinsic placental growth signaling","volume":"7","year":"2017","journal-title":"Theranostics"},{"issue":"13","key":"B118","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.7150\/thno.25608","article-title":"Cell-penetrating peptide-based nanovehicles potentiate lymph metastasis targeting and deep penetration for anti-metastasis therapy","volume":"8","year":"2018","journal-title":"Theranostics"},{"issue":"5","key":"B119","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1158\/2326-6066.CIR-14-0019-T","article-title":"Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes","volume":"2","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"B120","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1038\/s41467-020-19225-7","article-title":"Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy","volume":"11","year":"2020","journal-title":"Nat. Commun."},{"issue":"17","key":"B121","doi-asserted-by":"crossref","first-page":"1800025","DOI":"10.1002\/adfm.201800025","article-title":"iRGD modified chemo-immunotherapeutic nanoparticles for enhanced immunotherapy against glioblastoma","volume":"28","year":"2018","journal-title":"Adv. Funct. Mater."},{"issue":"15","key":"B122","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.7150\/thno.19678","article-title":"Selective targeting of a novel vasodilator to the uterine vasculature to treat impaired uteroplacental perfusion in pregnancy","volume":"7","year":"2017","journal-title":"Theranostics"},{"issue":"11","key":"B123","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3390\/pharmaceutics13111778","article-title":"Targeted delivery of epidermal growth factor to the human placenta to treat fetal growth restriction","volume":"13","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"B124","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1080\/10717544.2022.2126559","article-title":"Increased brain uptake of pterostilbene loaded folate modified micellar delivery system","volume":"29","year":"2022","journal-title":"Drug Deliv"},{"issue":"43","key":"B125","doi-asserted-by":"crossref","first-page":"39633","DOI":"10.1021\/acsami.9b14659","article-title":"Folate receptor \u03b1-modified nanoparticles for targeting of the central nervous system","volume":"11","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"41","key":"B126","doi-asserted-by":"crossref","first-page":"eabc7031","DOI":"10.1126\/sciadv.abc7031","article-title":"Blood-brain barrier\u2013penetrating siRNA nanomedicine for Alzheimer's disease therapy","volume":"6","year":"2020","journal-title":"Sci. Adv."},{"key":"B127","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fbioe.2020.00064","article-title":"Trophoblast-targeted nanomedicine modulates placental sFLT1 for preeclampsia treatment","volume":"8","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"810","key":"B128","first-page":"2765","article-title":"Placenta-specific drug delivery by trophoblast-targeted nanoparticles in mice","volume":"8","year":"2018","journal-title":"Theranostics"},{"issue":"1","key":"B129","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/10717544.2018.1435750","article-title":"Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment","volume":"25","year":"2018","journal-title":"Drug Deliv"},{"issue":"4","key":"B130","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1021\/acsnano.5b07573","article-title":"Increased nanoparticle delivery to brain tumors by autocatalytic priming for improved treatment and imaging","volume":"10","year":"2016","journal-title":"ACS Nano"},{"issue":"27","key":"B131","doi-asserted-by":"crossref","first-page":"1900259","DOI":"10.1002\/adfm.201900259","article-title":"Nanoparticles surmounting blood\u2013brain tumor barrier through both transcellular and paracellular pathways to target brain metastases","volume":"29","year":"2019","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"B132","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1038\/s41467-018-07250-6","article-title":"MR imaging tracking of inflammation-activatable engineered neutrophils for targeted therapy of surgically treated glioma","volume":"9","year":"2018","journal-title":"Nat. Commun."},{"issue":"7","key":"B133","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nnano.2017.54","article-title":"Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence","volume":"12","year":"2017","journal-title":"Nat. Nanotechnol."},{"issue":"7","key":"B134","doi-asserted-by":"crossref","first-page":"eaau8301","DOI":"10.1126\/sciadv.aau8301","article-title":"Accessing neuroinflammation sites: monocyte\/neutrophil-mediated drug delivery for cerebral ischemia","volume":"5","year":"2019","journal-title":"Sci. Adv."},{"issue":"9","key":"B135","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nm.2198","article-title":"Therapeutic cell engineering with surface-conjugated synthetic nanoparticles","volume":"16","year":"2010","journal-title":"Nat. Med."},{"issue":"291","key":"B136","first-page":"291ra94","article-title":"Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells","volume":"7","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"B137","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.biomaterials.2015.04.003","article-title":"Paracrine co-delivery of TGF- and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells","volume":"59","year":"2015","journal-title":"Biomaterials"},{"issue":"1","key":"B138","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/s41467-017-01830-8","article-title":"T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity","volume":"8","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"B139","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bioactmat.2020.08.017","article-title":"Macrophage membrane-coated nanocarriers co-modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice","volume":"6","year":"2021","journal-title":"Bioactive Mater"},{"issue":"16","key":"B140","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1021\/acs.nanolett.2c01863","article-title":"Engineered macrophage-membrane-coated nanoparticles with enhanced PD-1 expression induce immunomodulation for a synergistic and targeted antiglioblastoma activity","volume":"22","year":"2022","journal-title":"Nano Lett"},{"issue":"24","key":"B141","doi-asserted-by":"crossref","first-page":"27743","DOI":"10.1021\/acsami.2c09020","article-title":"Neutrophil-biomimetic ``nanobuffer'' for remodeling the microenvironment in the infarct core and protecting neurons in the penumbra via neutralization of detrimental factors to treat ischemic stroke","volume":"14","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"9","key":"B142","doi-asserted-by":"crossref","first-page":"11452","DOI":"10.1021\/acsnano.0c03824","article-title":"Natural-killer-cell-inspired nanorobots with aggregation-induced emission characteristics for near-infrared-II fluorescence-guided glioma theranostics","volume":"14","year":"2020","journal-title":"ACS Nano"},{"key":"B143","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2017.08.027","article-title":"A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery","volume":"264","year":"2017","journal-title":"J. Control. Release"},{"issue":"51","key":"B144","doi-asserted-by":"crossref","first-page":"1803717","DOI":"10.1002\/adma.201803717","article-title":"Effective and targeted human orthotopic glioblastoma xenograft therapy via a multifunctional biomimetic nanomedicine","volume":"30","year":"2018","journal-title":"Adv. Mater."},{"issue":"1","key":"B145","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1038\/s41467-022-31799-y","article-title":"Engineered biomimetic nanoparticles achieve targeted delivery and efficient metabolism-based synergistic therapy against glioblastoma","volume":"13","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"B146","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1021\/acsnano.8b06556","article-title":"Phototheranostics: active targeting of orthotopic glioma using biomimetic proteolipid nanoparticles","volume":"13","year":"2019","journal-title":"ACS Nano"},{"issue":"11","key":"B147","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/s41551-022-00938-7","article-title":"Variants of the adeno-associated virus serotype 9 with enhanced penetration of the blood\u2013brain barrier in rodents and primates","volume":"6","year":"2022","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"B148","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1038\/s41467-022-32837-5","article-title":"Bacteria loaded with glucose polymer and photosensitive ICG silicon-nanoparticles for glioblastoma photothermal immunotherapy","volume":"13","year":"2022","journal-title":"Nat. Commun."},{"key":"B149","doi-asserted-by":"crossref","first-page":"120784","DOI":"10.1016\/j.biomaterials.2021.120784","article-title":"Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy","volume":"273","year":"2021","journal-title":"Biomaterials"},{"issue":"1","key":"B150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12979-019-0150-2","article-title":"RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer's disease","volume":"16","year":"2019","journal-title":"Immun. Ageing"}],"container-title":["Annual Review of Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.annualreviews.org\/content\/journals\/10.1146\/annurev-bioeng-102723-021307?crawler=true&mimetype=application\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:45:08Z","timestamp":1777697108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.annualreviews.org\/content\/journals\/10.1146\/annurev-bioeng-102723-021307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1146\/annurev-bioeng-102723-021307","relation":{},"ISSN":["1523-9829","1545-4274"],"issn-type":[{"value":"1523-9829","type":"print"},{"value":"1545-4274","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}